UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

Learning from the comorbidities of epilepsy

Shlobin, NA; Sander, JW; (2022) Learning from the comorbidities of epilepsy. Current Opinion in Neurology , 35 (2) pp. 175-180. 10.1097/WCO.0000000000001010. Green open access

[thumbnail of Epilepsy Comorbidities Manuscript 10.13.21 final.pdf]
Preview
Text
Epilepsy Comorbidities Manuscript 10.13.21 final.pdf - Accepted Version

Download (298kB) | Preview

Abstract

PURPOSE OF REVIEW: Comorbidities are a common feature in epilepsy, but neither the entire spectrum nor the significance of such comorbidities has been fully explored. We review comorbidities associated with epilepsy and their associated burden, provide an overview of relationships, and discuss a new conceptualization of the comorbidities. RECENT FINDINGS: The epidemiology of the comorbidities of epilepsy and effects on health outcomes, healthcare use, and healthcare expenditures have been partly delineated. Distinct mechanisms of the associations have been suggested but not entirely ascertained. Movement from conceptualizing epilepsy as a condition to a symptom-complex has occurred. SUMMARY: Comorbidities are common among people with epilepsy and are associated with poorer clinical outcomes and quality of life, greater use of health resources, and increased expenditure. Becoming aware of the associated mechanisms and their uncertainty is central to understanding the relationships between epilepsy and comorbid health conditions, which have implications for diagnosis and screening, medical management, and surgical management. Conceptualizing comorbidities of epilepsy as precipitating factors and epilepsy as the symptom will improve the understanding of epilepsy and catalyze research and improvements in clinical practice.

Type: Article
Title: Learning from the comorbidities of epilepsy
Location: England
Open access status: An open access version is available from UCL Discovery
DOI: 10.1097/WCO.0000000000001010
Publisher version: http://doi.org/10.1097/WCO.0000000000001010
Language: English
Additional information: This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions.
Keywords: Antiepileptic drugs; antiseizure medications; outcomes; burden; seizures
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > UCL Queen Square Institute of Neurology > Clinical and Experimental Epilepsy
URI: https://discovery.ucl.ac.uk/id/eprint/10140714
Downloads since deposit
534Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item